BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10769703)

  • 1. Response of MHC class-1 antigen on rat glioma cells to cytokines.
    Oshiro S; Fukushima T; Tomonaga M; Black KL
    Anticancer Res; 2000; 20(1C):605-10. PubMed ID: 10769703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity and modified immunoregulation associated with IFN-gamma treatment of RG2 gliomas.
    Oshiro S; Fukushima T; Tomonaga M; Black KL
    Anticancer Res; 1999; 19(6B):5029-36. PubMed ID: 10697506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified immunoregulation associated with interferon-gamma treatment of rat glioma.
    Oshiro S; Liu Y; Fukushima T; Asotra K; Black KL
    Neurol Res; 2001 Jun; 23(4):359-66. PubMed ID: 11428516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas.
    Newcomb EW; Demaria S; Lukyanov Y; Shao Y; Schnee T; Kawashima N; Lan L; Dewyngaert JK; Zagzag D; McBride WH; Formenti SC
    Clin Cancer Res; 2006 Aug; 12(15):4730-7. PubMed ID: 16899624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
    Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired capacity for upregulation of MHC class II in tumor-associated microglia.
    Schartner JM; Hagar AR; Van Handel M; Zhang L; Nadkarni N; Badie B
    Glia; 2005 Sep; 51(4):279-85. PubMed ID: 15818597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells.
    Eisele G; Wischhusen J; Mittelbronn M; Meyermann R; Waldhauer I; Steinle A; Weller M; Friese MA
    Brain; 2006 Sep; 129(Pt 9):2416-25. PubMed ID: 16891318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
    Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
    Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
    Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity.
    Paul DB; Barth RF; Yang W; Shen GH; Kim J; Triozzi PL
    Gene Ther; 2000 Jun; 7(12):993-9. PubMed ID: 10871746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of adjustment of balance of Th1/Th2 type cytokines on proliferation of glioma cells].
    Hu YS; Zhang QL; Tian ZG; Wei HM; Zhang JH; Li G; Pang Q; Wang CW; Jin P; Sun R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):599-602. PubMed ID: 12901106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
    Friese MA; Platten M; Lutz SZ; Naumann U; Aulwurm S; Bischof F; Bühring HJ; Dichgans J; Rammensee HG; Steinle A; Weller M
    Cancer Res; 2003 Dec; 63(24):8996-9006. PubMed ID: 14695218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.
    Hussain SF; Yang D; Suki D; Aldape K; Grimm E; Heimberger AB
    Neuro Oncol; 2006 Jul; 8(3):261-79. PubMed ID: 16775224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of costimulatory molecules on human retinoblastoma cells Y-79: functional expression of CD40 and B7H1.
    Usui Y; Okunuki Y; Hattori T; Takeuchi M; Kezuka T; Goto H; Usui M
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4607-13. PubMed ID: 17003458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
    Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
    Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA).
    Takamura Y; Ikeda H; Kanaseki T; Toyota M; Tokino T; Imai K; Houkin K; Sato N
    Glia; 2004 Mar; 45(4):392-405. PubMed ID: 14966870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-I triple helix gene therapy of rat and human gliomas.
    Trojan LA; Kopinski P; Mazurek A; Chyczewski L; Ly A; Jarocki P; Nikliński J; Shevelev A; Trzos R; Pan Y; Gitis DJ; Bierwagen M; Czapiewska JL; Wei MX; Michalkiewicz J; Henin D; Popiela T; Evrard F; Kasprzak H; Anthony D; Trojan J
    Rocz Akad Med Bialymst; 2003; 48():18-27. PubMed ID: 14737936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
    Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
    J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.